Researchers at the Kennedy Institute join a collaboration to find new \u2018drug-free\u2019 ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.
Professor Michael Dustin and an international team of collaborators have been awarded a \u20ac10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.
Oxford University has today been awarded a \u00a32.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.
Investigators based at the Kennedy Institute of Rheumatology, NDORMS have recently received CRUK awards to increase understanding of a variety of cancers and immunotherapy.
The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of \u00a320M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.
Congratulations to Kennedy researchers Professor Chris Buckley, Professor Mark Coles and Dr Stephen Sansom who have been awarded \u00a31.5M funding from the Medical Research Council (MRC) to explore fibroblasts as an emerging target to treat chronic inflammatory disease.
Kennedy researchers, in collaboration with colleagues at the Botnar Research Centre, Oxford, and the Universities of Birmingham and Leeds, have been awarded strategic funding from the Medical Research Council (MRC) to map in detail the different types of cells that make up human joints.
We would like to congratulate Dr Luke Jostins-Dean on being awarded a 5-year Sir Henry Dale fellowship, joint funded by the Wellcome Trust and Royal Society, entitled \u2018combining genetics and high-resolution cell phenotyping to map pathways underlying inflammatory bowel disease\u2019.
We would like to congratulate Tariq Khoyratty, who has been appointed as a Celgene Fellow to study the link between neutrophil chromatin organisation in rheumatic patients and their ability to form pathogenic extracellular traps.
The University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) have won \u00a3113.7 million to support groundbreaking medical research.
![\"Tonia](\"https://www.kennedy.ox.ac.uk/news/researchers-from-the-kennedy-institute-awarded-mrc-funding-1/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n